Viral immune evasion: Lessons in MHC class I antigen presentation

Publication date

2015-01-01

Authors

van de Weijer, Michael L.
Luteijn, Rutger D.ISNI 0000000419536104
Wiertz, EJHJISNI 0000000048041814

Editors

Advisors

Supervisors

Document Type

Article

Collections

Open Access logo

License

taverne

Abstract

The MHC class I antigen presentation pathway enables cells infected with intracellular pathogens to signal the presence of the invader to the immune system. Cytotoxic T lymphocytes are able to eliminate the infected cells through recognition of pathogen-derived peptides presented by MHC class I molecules at the cell surface. In the course of evolution, many viruses have acquired inhibitors that target essential stages of the MHC class I antigen presentation pathway. Studies on these immune evasion proteins reveal fascinating strategies used by viruses to elude the immune system. Viral immunoevasins also constitute great research tools that facilitate functional studies on the MHC class I antigen presentation pathway, allowing the investigation of less well understood routes, such as TAP-independent antigen presentation and cross-presentation of exogenous proteins. Viral immunoevasins have also helped to unravel more general cellular processes. For instance, basic principles of ER-associated protein degradation via the ubiquitin-proteasome pathway have been resolved using virus-induced degradation of MHC class I as a model. This review highlights how viral immunoevasins have increased our understanding of MHC class I-restricted antigen presentation.

Keywords

Cross-presentation, ERAD, Immune evasion, MHC class I, MHC class II, PLC, TAP, Viral inhibitors, Taverne, Immunology and Allergy, Immunology, Journal Article, Review

Citation

van de Weijer, M L, Luteijn, R D & Wiertz, EJHJ 2015, 'Viral immune evasion : Lessons in MHC class I antigen presentation', Semin Immunology, vol. 27, no. 2, pp. 125-137. https://doi.org/10.1016/j.smim.2015.03.010